| Product Code: ETC6135310 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Argentina`s import trend for cyclooxygenase 2 inhibitors in 2024 experienced a notable decline, with a growth rate of -35.29% compared to the previous year. The compound annual growth rate (CAGR) for the period 2020-2024 stood at -25.13%. This significant decrease in imports could be attributed to shifting demand patterns, changes in trade policies, or a potential market contraction that impacted the import momentum for this pharmaceutical segment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Cyclooxygenase 2 Inhibitor Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle |
3.4 Argentina Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces |
3.5 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Argentina Cyclooxygenase 2 Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic inflammatory conditions in Argentina |
4.2.2 Growing awareness about the benefits of cyclooxygenase 2 inhibitors in managing pain and inflammation |
4.2.3 Rising healthcare expenditure and improving access to advanced pharmaceuticals in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing in Argentina |
4.3.2 Potential side effects and safety concerns associated with cyclooxygenase 2 inhibitors |
4.3.3 Competition from alternative pain management therapies in the market |
5 Argentina Cyclooxygenase 2 Inhibitor Market Trends |
6 Argentina Cyclooxygenase 2 Inhibitor Market, By Types |
6.1 Argentina Cyclooxygenase 2 Inhibitor Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2021- 2031F |
6.1.4 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2021- 2031F |
6.1.5 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2021- 2031F |
6.1.6 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2021- 2031F |
6.1.7 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Argentina Cyclooxygenase 2 Inhibitor Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2021- 2031F |
6.2.3 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2021- 2031F |
6.3 Argentina Cyclooxygenase 2 Inhibitor Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.3.3 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2021- 2031F |
6.3.4 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Argentina Cyclooxygenase 2 Inhibitor Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Argentina Cyclooxygenase 2 Inhibitor Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Argentina Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
7 Argentina Cyclooxygenase 2 Inhibitor Market Import-Export Trade Statistics |
7.1 Argentina Cyclooxygenase 2 Inhibitor Market Export to Major Countries |
7.2 Argentina Cyclooxygenase 2 Inhibitor Market Imports from Major Countries |
8 Argentina Cyclooxygenase 2 Inhibitor Market Key Performance Indicators |
8.1 Patient adherence rate to cyclooxygenase 2 inhibitor treatment |
8.2 Number of clinical trials and research studies on cyclooxygenase 2 inhibitors in Argentina |
8.3 Prescription rates of cyclooxygenase 2 inhibitors by healthcare providers in the country |
9 Argentina Cyclooxygenase 2 Inhibitor Market - Opportunity Assessment |
9.1 Argentina Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Argentina Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Argentina Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Argentina Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Argentina Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Cyclooxygenase 2 Inhibitor Market - Competitive Landscape |
10.1 Argentina Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2024 |
10.2 Argentina Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here